Pasithea Therapeutics News

EFFECT: Others

Oct 15 06:12 ET

424B3: Prospectus

Oct 11 17:14 ET

Pasithea Therapeutics | EFFECT: Others

Apr 3 06:07 ET

Pasithea Therapeutics | 424B3: Prospectus

Jun 6, 2023 17:04 ET

Pasithea Therapeutics | EFFECT: Others

Jun 6, 2023 00:15 ET

Pasithea Therapeutics | EFFECT: Others

Apr 20, 2023 00:15 ET

Pasithea Therapeutics | 424B3: Prospectus

Nov 30, 2022 16:02 ET

Pasithea Therapeutics | 424B3: Prospectus

Nov 30, 2022 16:01 ET

Pasithea Therapeutics | 424B3: Prospectus

Sep 16, 2022 16:32 ET

Pasithea Therapeutics | 424B3: Prospectus

Sep 16, 2022 16:30 ET

Pasithea Therapeutics | 424B3: Prospectus

Apr 18, 2022 16:20 ET

Pasithea Therapeutics | 424B3: Prospectus

Apr 18, 2022 16:10 ET

Pasithea Therapeutics | 424B3: Prospectus

Dec 22, 2021 17:00 ET

Pasithea Therapeutics | 424B3: Prospectus

Dec 21, 2021 06:09 ET

Pasithea Therapeutics | 424B3: Prospectus

Dec 21, 2021 06:03 ET

Pasithea Therapeutics | EFFECT: Others

Dec 17, 2021 00:15 ET

Pasithea Therapeutics | 424B4: Prospectus

Sep 16, 2021 17:11 ET

Pasithea Therapeutics | EFFECT: Others

Sep 15, 2021 00:15 ET

Pasithea Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

Sep 13, 2021 16:05 ET

Pasithea Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Aug 26, 2021 18:26 ET